montelukast accord 5 mg comprimidos masticables efg
accord healthcare s.l.u. - montelukast sodico - comprimido masticable - 5 mg - montelukast sodico 5 mg - montelukast
propranolol accord 10 mg comprimidos recubiertos con pelicula efg
accord healthcare s.l.u. - propranolol - comprimido recubierto con pelÍcula - 10 mg - propranolol 10 mg - propranolol
propranolol accord 40 mg comprimidos recubiertos con pelicula efg
accord healthcare s.l.u. - propranolol - comprimido recubierto con pelÍcula - 40 mg - propranolol 40 mg - propranolol
espironolactona accord 100 mg comprimidos recubiertos con pelicula efg
accord healthcare s.l.u. - espironolactona - comprimido recubierto con pelÍcula - 100 mg - espironolactona 100 mg - espironolactona
espironolactona accord 25 mg comprimidos recubiertos con pelicula efg
accord healthcare s.l.u. - espironolactona - comprimido recubierto con pelÍcula - 25 mg - espironolactona 25 mg - espironolactona
propafenona hidrocloruro accord 150 mg comprimidos recubiertos con pelicula efg
accord healthcare s.l.u. - propafenona hidrocloruro - comprimido recubierto con pelÍcula - 150 mg - propafenona hidrocloruro 150 mg - propafenona
propafenona hidrocloruro accord 300 mg comprimidos recubiertos con pelicula efg
accord healthcare s.l.u. - propafenona hidrocloruro - comprimido recubierto con pelÍcula - 300 mg - propafenona hidrocloruro 300 mg - propafenona
vinorelbina accord 10 mg/ml concentrado para solucion para perfusion efg
accord healthcare s.l.u. - vinorelbina tartrato - concentrado para soluciÓn para perfusiÓn - 10 mg/ml inyectable 5 ml - vinorelbina tartrato 10 mg - vinorelbina
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
tolvaptan accord
accord healthcare s.l.u. - tolvaptan - síndrome de adh inapropiado - los diuréticos, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).